Jointly sponsored by Creative Educational Concepts, Inc and Princeton CME
Target Audience
This activity is designed for managed markets and hospital-based physicians, pharmacists, and nurses.
Learning Objectives
After completing this activity, participants should be able to:
- Identify patients with hypertension who are at high risk for the associated comorbidities that include diabetes, kidney disease, dyslipidemia, myocardial infarction, and stroke so that the progression to these comorbid conditions is delayed or prevented
- Evaluate the long term economic burden placed on the healthcare system by patients with hypertension who are at risk for associated comorbidities so that these patients can be better managed
- Propose strategies for pharmacotherapy management to reduce the consequences of uncontrolled hypertension
- Achieve a reduction in the comorbidities associated with uncontrolled hypertension by implementing the evidence-based information from recent, ongoing, and future clinical trials that support the importance of management of hypertension in these high risk patients
Credit Eligibility
To be eligible for documentation of credit, participants must participate in the full educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Release date: December 27, 2007; Expiration date: December 27, 2008
Estimated time to complete: 1 hour
There is no fee associated with this activity.
Lecture Components
The presentation slides, post-test, and evaluation form are available as a click through via the menu at the top of each page of this educational activity.
CME Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Creative Educational Concepts, Inc (CEC) and Princeton CME. CEC is accredited by the ACCME to provide continuing medical education for physicians.
CEC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CPE Accreditation
Creative Educational Concepts, Inc (CEC) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program has been assigned ACPE #245-999-07-112-H01-P and will award 1.0 contact hours (0.100 CEUs) of continuing pharmacy education credit. CEC complies with the Criteria for Quality for continuing education programming.
CNE Accreditation
Eastern Kentucky University, the Division of Continuing Education and Development, is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Eastern Kentucky University, the Division of Continuing Education and Development, designates this educational activity for 1.0 contact hours. This activity will provide 1.0 contact hours of nursing credit. Licensees are required to retain certificates of completion for a period of five (5) years following the end of their licensure period and submit certificate to the Board of Nursing only upon request.
Grant Support
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Participating Faculty
Presenters
Donna M. Polk, MD, MPH, FACC
Assistant Medical Director
Preventive and Rehabilitative Cardiac Center
Medical Director, LDL Apheresis Program
Associate Director, Cardiology Fellowship Training Program
Cedars-Sinai Medical Center
Preventive & Rehabilitative Cardiac Center
Los Angeles, California
Michael P. Dorsch, PharmD, BCPS
Clinical Pharmacist, Cardiology
Adjunct Clinical Instructor
Department of Pharmacy Services
University of Michigan Hospitals and Health Centers
Ann Arbor, Michigan
Independent Clinical Reviewer
Karol E. Watson, MD, PhD, FACC
Associate Professor of Medicine, Cardiology
Codirector UCLA Program in Preventive Cardiology
David Geffen School of Medicine at UCLA
Los Angeles, California
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of Creative Educational Concepts, Inc (CEC) and Princeton CME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of CEC and Princeton CME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Polk: Grant/Research support—Kos Pharmaceuticals; Speaker’s bureau—Pfizer
Dr. Watson: Consultant and speaker’s bureau—Abbott, Astra Zeneca, Merck and Co., Inc, Shering-Plough Corporation, Takeda, sanofi-aventis U.S.
Dr. Dorsch disclosed no relevant financial relationships with any commercial interests.
Planning Committee Pam Calvert and Janet Cline, CEC; Randy Robbin and John Savage, Princeton CME; Kristin Dickie and Mary Johnson, Princeton Media Communications have disclosed no relevant financial relationships with any commercial interests.
CEC and Princeton CME requires faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentation.
The faculty has disclosed that no off-label/unapproved uses of drugs or devices will be discussed.
